sugarcane allergenic extract 50 MG/ML Injectable Solution

Known as: SUGARCANE 0.05 g in 1 mL INTRADERMAL INJECTION, SOLUTION, sugarcane extract 50 MG/ML Injectable Solution, sugarcane extract 0.05 GM/ML Injectable Solution 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Sugarcane bagasse (SCB) is abundantly available agro-waste world-wide and has been used in different applications and its… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2010
2010
Amenability to tissue culture stages required for gene transfer, selection and plant regeneration are the main determinants of… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Renewable sources have recently emerged as a generation option for many countries in order to promote clean energy development… (More)
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 4
Is this relevant?
2009
2009
The potential to reduce emissions from agriculture and increase the amount of carbon captured in soils is currently being… (More)
  • figure 1
  • table 1
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Target region amplification polymorphism (TRAP) is a fairly new PCR-based molecular marker technique which uses gene-based… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
To contribute to our understanding of the genome complexity of sugarcane, we undertook a large-scale expressed sequence tag (EST… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
1987
1987
Sugarcane protoplasts were transformed to kanamycin resistance at a frequency of approximately 8 in 107 following PEG-induced… (More)
  • table 2
  • figure I
Is this relevant?